Improving health for cancer patients through a mobile health intervention
Official title: Changing Mindsets to Improve Whole Patient Health: A Randomized Controlled Trial of a Novel mHealth Intervention for People Diagnosed with Cancer
Funded at Stanford University · NIH-11039944 · Data updated 2026-11-12
This study is testing a new mobile health program to help people with cancer feel better both mentally and physically during their treatment, especially those going through chemotherapy, by offering support for anxiety and depression alongside regular medical care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | February 19, 2024 |
| Project end | November 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $669,453 |
| NIH project number | 5R01AT012618-02 |
| Project ID | NIH-11039944 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with cancer who are currently undergoing chemotherapy and experiencing psychological symptoms such as anxiety or depression.
✕Less likely to help
Patients who are not currently undergoing cancer treatment or those without a cancer diagnosis may not benefit from this research.
What this research studies
This research investigates a new mobile health intervention designed to improve the overall health and quality of life for individuals diagnosed with cancer. It addresses the psychological and physical challenges faced by cancer patients, particularly those undergoing chemotherapy, by integrating mental health support with traditional medical care. The intervention aims to provide accessible strategies to manage anxiety, depression, and other symptoms that can arise during cancer treatment, ultimately enhancing patients' well-being. Participants will be randomly assigned to receive either the intervention or standard care, allowing researchers to evaluate its effectiveness.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life for cancer patients by providing effective mental health support alongside their medical treatment.
How similar studies have gone: Previous research has shown that integrated mental health interventions can improve outcomes for cancer patients, suggesting that this approach may be effective.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Crum, Alia — Stanford University
- Study coordinator: Crum, Alia
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.